Home › Funds › BRC Group Holdings, Inc. › TOI
BRC Group Holdings, Inc. position in TOI
STARLING ONCOLOGY INC
BRC Group Holdings, Inc. reported holding 722,381 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 2.48% of its reported portfolio and ranking #2 among its reported holdings. BRC Group Holdings, Inc. has disclosed TOI holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How BRC Group Holdings, Inc.'s TOI position evolved
BRC Group Holdings, Inc. first disclosed a stake in TOI in Q1 2025 at 150,000 shares (US$171K). The position peaked in Q3 2026 at 722,381 shares, worth US$4.6M. Across 7 filings, BRC Group Holdings, Inc. increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 722,381 shares valued at US$4.6M — a reduction of -20,212 shares quarter over quarter.. Notable position changes include a 208% increase in Q2 2025, a 76% increase in Q3 2025, a 40% increase in Q1 2026.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 150.00K | $171.00K | New |
| Q2 2025 | 462.00K | $947.10K | Add |
| Q3 2025 | 811.55K | $2.83M | Add |
| Q4 2025 | 663.38K | $2.36M | Reduce |
| Q1 2026 | 929.73K | $2.85M | Add |
| Q2 2026 | 742.59K | $4.03M | Reduce |
| Q3 2026 | 722.38K | $4.57M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TOI and 13F data
TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$10.8M), FourWorld Capital Management LLC (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TOI
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.46M sh · $13.38M · Q2 2026
- WEXFORD CAPITAL LP 1.71M sh · $10.82M · Q3 2026
- FourWorld Capital Management LLC 499.20K sh · $2.71M · Q2 2026
- Manatuck Hill Partners, LLC 450.00K sh · $2.44M · Q2 2026
- FORMULA GROWTH LTD 368.40K sh · $2.33M · Q3 2026
- Dauntless Investment Group, LLC 163.57K sh · $888.18K · Q2 2026
- Panoramic Capital, LLC 100.00K sh · $543.00K · Q2 2026
- Spark Investment Management LLC 72.80K sh · $460.10K · Q3 2026
- T3 Companies, LLC 64.50K sh · $407.64K · Q3 2026
More on BRC Group Holdings, Inc.
FAQ
How long has BRC Group Holdings, Inc. held TOI?
BRC Group Holdings, Inc. has disclosed TOI holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is BRC Group Holdings, Inc.'s current position in TOI?
As of Q3 2026, BRC Group Holdings, Inc. holds 722.38K shares of TOI (STARLING ONCOLOGY INC), valued at $4.57M, representing 2.48% of its reported portfolio and ranking #2.
Has BRC Group Holdings, Inc. been buying or selling TOI?
In the latest 13F filing (Q3 2026), BRC Group Holdings, Inc. reduced its position in TOI. The position peaked in Q3 2026 at 722.38K shares.
Which other funds hold TOI?
Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, FourWorld Capital Management LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.